IP Library › Granted Patent US 8,114,623
Granted Patent B2
US 8,114,623 · App. 11/936,569 · Granted Feb 14, 2012

Method for determining glucose concentration in tissue fluid

Assignee: Roche Diagnostics Operations, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,114,623
App. No.
11/936,569
Granted
Feb 14, 2012
Kind
B2
Abstract

The invention relates to a method and a device for determining the glucose concentration in tissue fluid whereby test values for glucose and for an endogenous reference substance are detected in a sample liquid obtained by microdialysis, microperfusion or ultrafiltration, and the glucose value is corrected in accordance with the test value for the reference substance. The recovery rate for glucose is determined from a non-linear relationship with the recovery rate for the ionic reference substance, and the test value for glucose is corrected therewith. In addition, the concentration of lactate and/or pyruvate is used as a further reference substance in the sample liquid to make further corrections.

Claims (7)

1. A method for determining glucose concentration in a tissue fluid in a body, the method comprising the steps of:

measuring a glucose concentration in a sample of the tissue fluid obtained by a technique selected from the group consisting of microdialysis, microperfusion, and ultrafiltration;

measuring a concentration of at least one reference substance in the sample of the tissue fluid; the at least one reference substance including lactate and pyruvate;

determining the glucose concentration of the tissue fluid in the body based upon the measured concentration of the at least one reference substance and glucose in the sample of the tissue fluid.

2. The method as set forth in claim 1 further including the step of determining a concentration ratio of lactate to pyruvate in the sample of the tissue fluid in order to determine the glucose concentration in the tissue fluid in the body.

3. The method as set forth in claim 2 further including the step of utilizing a linear correction factor to determine the glucose concentration in the tissue fluid in the body when the concentration ratio of lactate to pyruvate in the sample of the tissue fluid is within the range between about 10:1 to about 20:1.

4. The method as set forth in claim 2 further including the step of utilizing a constant to determine the glucose concentration in the tissue fluid in the body when the concentration ratio of lactate to pyruvate in the sample of the tissue fluid is about 20:1.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2008
From: ROCHE DIAGNOSTICS GMBH
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 021009/0356 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2008
From: FERRARI, STEFANO; QUARDER, ORTRUD; STEPHAN, PETER
To: ROCHE DIAGNOSTICS GMBH
Reel/Frame 020621/0702 →
Priority Claims (1)
EP 05009986 · May 7, 2005 · regional
Continuity (2)
Continuation PCTEP2006004179 · May 4, 2006
Related Publication 20080153118A1 · Jun 26, 2008